EP3283107
SAMSETNINGAR SEM FELA Í SÉR SAMSETNINGU AF IPILIMUMAB OG NIVOLUMAB
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.4.2016EP published:
27.5.2020EP application number:
16718835.8
EP translation filed:
22.7.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
14.4.2036Expiry date:
14.4.2026Next due date:
30.4.2026
Title:
COMPOSITIONS COMPRISING A COMBINATION OF IPILIMUMAB AND NIVOLUMAB
Timeline
Today
15.4.2016EP application
27.5.2020EP Publication
22.7.2020Translation submitted
15.9.2020Registration published
14.4.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
SADINENI, VikramAddress:
Princeton, New Jersey 08543, US
Name:
QUAN, YongAddress:
Princeton, New Jersey 08543, US
Name:
KASERER, WallaceAddress:
Lawrence Township, New Jersey 08648, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562149325 PDate:
17.4.2015Country:
US
Number:
201562265268 PDate:
9.12.2015Country:
US
Number:
201562269000 PDate:
17.12.2015Country:
US
Number:
201662303855 PDate:
4.3.2016Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 10.3.2021
Expires: 14.4.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.3.2022
Expires: 14.4.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.3.2023
Expires: 14.4.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.3.2024
Expires: 14.4.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.3.2025
Expires: 14.4.2026
Payer: Árnason Faktor ehf.